Evidence map›Paper›PMID 28614350›Full record

SynthesisPLoS genetics2017

Ranking and characterization of established BMI and lipid associated loci as candidates for gene-environment interactions.

Dmitry Shungin, Wei Q Deng, Tibor V Varga, Jian'an Luan, Evelin Mihailov, Andres Metspalu, GIANT Consortium, Andrew P Morris, Nita G Forouhi, Cecilia Lindgren and 21 more

Open access · goldAbstract readMeta-Analysis
In one paragraph

Synthesis in PLoS genetics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Distinct explanations underlie gene-environment interactions in the UK Biobank.medRxiv : the preprint server for health sciences · 2024
    Article
  8. Article
  9. Sortilin as a Biomarker for Cardiovascular Disease Revisited.Frontiers in cardiovascular medicine · 2021
    Article
  10. Article
  11. Article
  12. Review
  13. Gene-lifestyle interplay in type 2 diabetes.Current opinion in genetics & development · 2018
    Review
  14. Review
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

31 authors at 16 institutions in 7 countries.

Dmitry ShunginDepartment of Clinical Sciences, Genetic & Molecular Epidemiology Unit, Lund University Diabetes Centre, Skåne University Hospital, Malmö, Sweden.
Wei Q DengDepartment of Statistical Sciences, University of Toronto, Toronto, Canada.
Tibor V VargaDepartment of Clinical Sciences, Genetic & Molecular Epidemiology Unit, Lund University Diabetes Centre, Skåne University Hospital, Malmö, Sweden.ORCID http://orcid.org/0000-0002-2383-699X
Jian'an LuanMRC Epidemiology Unit, University of Cambridge, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
Evelin MihailovEstonian Genome Center, University of Tartu, Tartu, Estonia.
Andres MetspaluEstonian Genome Center, University of Tartu, Tartu, Estonia.
GIANT Consortium
Andrew P MorrisEstonian Genome Center, University of Tartu, Tartu, Estonia.ORCID http://orcid.org/0000-0002-6805-6014
Nita G ForouhiMRC Epidemiology Unit, University of Cambridge, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
Cecilia LindgrenBroad Institute of the Massachusetts Institute of Technology and Harvard University, Cambridge, MA, United States of America.ORCID http://orcid.org/0000-0002-4903-9374
Patrik K E MagnussonDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Nancy L PedersenDepartment of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden.
Göran HallmansDepartment of Biobank Research, Umeå University, Umeå, Sweden.
Audrey Y ChuHarvard Medical School, Boston, MA, United States of America.
Anne E JusticeDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Mariaelisa GraffDepartment of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, United States of America.
Thomas W WinklerDepartment of Genetic Epidemiology, University of Regensburg, Regensburg, DE, Germany.ORCID http://orcid.org/0000-0003-0292-5421
Lynda M RoseDivision of Preventive Medicine, Brigham and Women's Hospital, Boston, MA, United States of America.
Claudia LangenbergMRC Epidemiology Unit, University of Cambridge, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
L Adrienne CupplesDepartment of Biostatistics, Boston University School of Public Health, Boston, MA.
Paul M RidkerHarvard Medical School, Boston, MA, United States of America.
Nicholas J WarehamMRC Epidemiology Unit, University of Cambridge, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.ORCID http://orcid.org/0000-0003-1422-2993
Ken K OngMRC Epidemiology Unit, University of Cambridge, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
Ruth J F LoosThe Genetics of Obesity and Related Metabolic Traits Program, Icahn School of Medicine at Mount Sinai, New York, NY.
Daniel I ChasmanHarvard Medical School, Boston, MA, United States of America.
Erik IngelssonScience for Life Laboratory, Uppsala University, Uppsala, Sweden.
Tuomas O KilpeläinenThe Novo Nordisk Foundation Center for Basic Metabolic Research, Section of Metabolic Genetics, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
Robert A ScottMRC Epidemiology Unit, University of Cambridge, Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, United Kingdom.
Reedik MägiEstonian Genome Center, University of Tartu, Tartu, Estonia.
Guillaume ParéDepartment of Pathology and Molecular Medicine, McMaster University, Hamilton, Canada.ORCID http://orcid.org/0000-0002-6795-4760
Paul W FranksDepartment of Clinical Sciences, Genetic & Molecular Epidemiology Unit, Lund University Diabetes Centre, Skåne University Hospital, Malmö, Sweden.
University of Cambridge · GBBrigham and Women's Hospital · USBroad Institute · USCentre for Human Genetics · GBHarvard University · USKarolinska Institutet · SEUniversity of Copenhagen · DKUniversity of North Carolina at Chapel Hill · USUniversity of Tartu · EEBoston University · USChild Health and Development Institute · USMcMaster University · CAUmeå University · SEUniversity of Regensburg · DEUniversity of Toronto · CAUppsala University · SE

Funding

Translational Research CoreP30DK020541 · NIDDK · ALBERT EINSTEIN COLLEGE OF MEDICINE, INC · PI STREAMSON C CHUA · 2015 to 2026
$27.7M
Research Services CoreP2CHD050924 · NICHD · UNIV OF NORTH CAROLINA CHAPEL HILL · PI KAREN B GUZZO · 2015 to 2026
$9.6M
Epigenetics of Chronic Kidney DiseaseR01DK087635 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KATALIN SUSZTAK · 2009 to 2026
$7.0M
Genetic Architecture of Adiposity in Multiple Large CohortsR01DK089256 · NIDDK · WASHINGTON UNIVERSITY · PI BARANSKI, THOMAS JOHN, LIU, CHING-TI · 2010 to 2016
$4.6M
Diverse ancestry biobank to map biomedical traits and elucidate health disparitieU01HG007417 · NHGRI · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI LOOS, RUTH JF · 2013 to 2017
$3.5M
Epigenetic drivers and biomarkers of diabetic kidney diseaseDP3DK108220 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SUSZTAK, KATALIN · 2015 to 2015
$2.4M
Beyond GWAS of insulin resistance: An integrated approach to translate genetic association to functionR01DK106236 · NIDDK · STANFORD UNIVERSITY · PI KNOWLES, JOSHUA WILEY · 2016 to 2020
$2.4M
Leveraging ancestral diversity to map adiposity loci in HispanicsR01DK101855 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI HAIMAN, CHRISTOPHER ALAN, LOOS, RUTH JF · 2014 to 2016
$2.1M
Sex- and Smoking- Specific DNA Methylation Signatures of Central Adiposity ChangeK99HL130580 · NHLBI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI JUSTICE, ANNE · 2016 to 2017
$217k
Medical Research Council MC_UU_12015/1Medical Research Council MC_UU_12015/2Medical Research Council MC_UU_12015/5Medical Research Council MC_UU_12015/7NHGRI NIH HHS U01 HG007417NHLBI NIH HHS K99 HL130580NICHD NIH HHS P2C HD050924NIDDK NIH HHS DP3 DK108220NIDDK NIH HHS P30 DK020541NIDDK NIH HHS R01 DK087635NIDDK NIH HHS R01 DK089256NIDDK NIH HHS R01 DK101855NIDDK NIH HHS R01 DK106236
6 · The paper itself

Abstract

Phenotypic variance heterogeneity across genotypes at a single nucleotide polymorphism (SNP) may reflect underlying gene-environment (G×E) or gene-gene interactions. We modeled variance heterogeneity for blood lipids and BMI in up to 44,211 participants and investigated relationships between variance effects (Pv), G×E interaction effects (with smoking and physical activity), and marginal genetic effects (Pm). Correlations between Pv and Pm were stronger for SNPs with established marginal effects (Spearman's ρ = 0.401 for triglycerides, and ρ = 0.236 for BMI) compared to all SNPs. When Pv and Pm were compared for all pruned SNPs, only BMI was statistically significant (Spearman's ρ = 0.010). Overall, SNPs with established marginal effects were overrepresented in the nominally significant part of the Pv distribution (Pbinomial <0.05). SNPs from the top 1% of the Pm distribution for BMI had more significant Pv values (PMann-Whitney = 1.46×10-5), and the odds ratio of SNPs with nominally significant (<0.05) Pm and Pv was 1.33 (95% CI: 1.12, 1.57) for BMI. Moreover, BMI SNPs with nominally significant G×E interaction P-values (Pint<0.05) were enriched with nominally significant Pv values (Pbinomial = 8.63×10-9 and 8.52×10-7 for SNP × smoking and SNP × physical activity, respectively). We conclude that some loci with strong marginal effects may be good candidates for G×E, and variance-based prioritization can be used to identify them.

Indexed as

Gene-Environment InteractionBody Mass IndexCholesterol, HDLCholesterol, LDLFemaleGenetic HeterogeneityGenetic Predisposition to DiseaseGenome-Wide Association StudyGenotypeHumansMaleObesityPolymorphism, Single NucleotideQuantitative Trait LociRisk FactorsSmokingCholesterol, HDLCholesterol, LDL

Identifiers

PMID28614350
PMCPMC5489225
OpenAlexW2657905489

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.